Assessment and management of magnesium and trace element status in children with CKD stages 2-5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce
- PMID: 40379985
- PMCID: PMC12402044
- DOI: 10.1007/s00467-025-06759-5
Assessment and management of magnesium and trace element status in children with CKD stages 2-5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce
Abstract
Children and young people with chronic kidney disease (CKD) are at risk for deficiency or excess of magnesium and trace elements. Kidney function, dialysis, medication, and dietary and supplemental intake can affect their biochemical status. There is much uncertainty about the requirements of magnesium and trace elements in CKD, which leads to variation in practice. The Pediatric Renal Nutrition Taskforce is an international team of pediatric kidney dietitians and pediatric nephrologists, formed to develop evidence-based clinical practice points to improve the nutritional care of children with CKD. PICO (patient, intervention, comparator, and outcomes) questions led the literature searches, which were conducted to ascertain current biochemical status, dietary intake, and factors leading to requirements differing from healthy peers, and to guide nutritional care of children with CKD stages 2-5, on dialysis, and post-transplantation. We address the assessment and intervention of magnesium and the trace elements chromium, copper, fluoride, iodine, manganese, selenium, and zinc. We suggest routine biochemical assessment of magnesium. Trace element assessment is based on clinical suspicion of deficiency or excess and their risk factors, including accumulation, losses, medications, nutrient interactions, and comorbidities. In particular, we suggest assessing magnesium, copper, iodine, and zinc when growth is poor, and evaluating magnesium, copper, selenium, and zinc in the presence of proteinuria. A structured approach to magnesium and trace element management, including biochemical, physical, and dietary assessment, is beneficial in the paucity of evidence. Research recommendations are suggested.
Keywords: Children; Chronic kidney disease; Clinical practice points; Magnesium; Minerals; Pediatric Renal Nutrition Taskforce; Trace elements.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
References
-
- WHO (2004) Vitamin and mineral requirements in human nutrition, 2nd edn. World Health Organization, Geneva
-
- Davenport A (2015) Chapter 36 - Trace elements in patients with chronic kidney disease. In: Kimmel PL, Rosenberg ME (eds) Chronic renal disease. Academic Press, San Diego, pp 429–439
-
- Coleman J, Edefonti A, Watson AR (2001) Guidelines by an AD HOC European committee on the assessment of growth and nutritional status in children on chronic peritoneal dialysis. Perit Dial Int 21:1–9. 10.1177/089686080102100321 - DOI
-
- McAlister L, Pugh P, Greenbaum L et al (2020) The dietary management of calcium and phosphate in children with CKD stages 2–5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 35:501–518. https://link.springer.com/article/, 10.1007/s00467-019-04370-z - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
